Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000205357 | SCV000260977 | benign | Hypertrophic cardiomyopathy | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000246823 | SCV000318718 | likely benign | Cardiovascular phenotype | 2018-08-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001722126 | SCV000524616 | likely benign | not provided | 2020-09-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625202 | SCV000744114 | likely benign | Hypertrophic cardiomyopathy 17 | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852953 | SCV000995700 | benign | Cardiomyopathy | 2019-01-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001722126 | SCV001157621 | benign | not provided | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003937783 | SCV004754769 | benign | JPH2-related disorder | 2019-11-11 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000424518 | SCV001921225 | benign | not specified | no assertion criteria provided | clinical testing |